低分子肝素治疗急性冠脉综合症的临床试验分析
被引量:6
摘要
本文对低分子肝素治疗急性冠脉综合症的三个临床试验 (FRAXIS ,FRIC ,ESSENCE)进行了分析与评价 。
出处
《实用心脑肺血管病杂志》
2002年第1期45-52,共8页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
参考文献14
-
1[1]Gurfinkel EP,Manos EJ,Mejail RI,et al.Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia.J Am Coll Cardiol.1995,26:313~318.
-
2[2]Fragmin During Instability in Coronary Artery Disease(FRISC) study group.Low molecular weight heparin during instability in CAD.Lancet.1996,347:561~568.
-
3[3]FRAX.I.S study group.Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction:FRAX.I.S.(FRAxiparine in Ischaemic Syndrome).Eur Heart J.1999,20(21):1553~1562.
-
4[4]Klein W,Buchwald A,Hillis SE,et al.Comparison of low molecular weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease.Fragmin in unstable coronary artery disease study (FRIC).Circulation.1997,96:61~68.
-
5[5]Cohen M,Demers C,Gurfinkel FP,et al.A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease.N Ehgl J Med.1997,337:447~452.
-
6[6]Antman EM,Mcgabe CH,Gurfinkel EP,et al.For the TIMI 11B Investigators.Enoxaparin prevents death and cardiac ischemic events in unstable angina/non Q-wave myocardial infarction:results of the thrombolysis in myocardial infarction (TIMI) 11B trial.Circulation.1999,100:1593~1601.
-
7[7]Fragmin and fast revascularization during instability in coronary artery disease (FRISC Ⅱ) investigators.Long-term low molecular mass heparin in unstable coronary artery disease:FRISC Ⅱ prospective randomized multicentre study.Fragmin and fast revascularisation during instability in coronary artery disease.Investigators.Lancet.1999,354:701~707.
-
8[8]Weita JI.Low-molecular-weight heparins.N Engl J Med.1997,338:688~698.
-
9[9]Samama MM,Bara L,Gouin-Thibault.New data on the pharmacology of heparin and low molecular weight heparins.Drugs.1996,52(7):8~15.
-
10[10]Monrad ES.Role of low molecular weight heparins in the management of patients with unstable angina pectoris and non Q wave acute myocardial infarction.Am J Cardiol.2000,85:2C~9C.
同被引文献27
-
1蔡景龙,郑淑欣,姚兴会.门奇静脉断流术后门脉系统血栓形成的研究近况[J].新消化病学杂志,1995,3(3):160-160. 被引量:3
-
2邱贵兴,戴尅戎,杨庆铭,裴福兴,陈百成,曾炳芳,陈安民,王坤正,王继芳,余楠生,周乙雄,孙天胜,刘强,胡永成.预防骨科大手术后深静脉血栓形成的专家建议——深静脉血栓形成预防座谈会纪要[J].中华骨科杂志,2005,25(10):636-640. 被引量:477
-
3李婧,邱贵兴.静脉血栓栓塞在骨科的预防与治疗[J].中华骨科杂志,2005,25(12):740-743. 被引量:90
-
4张治云,凌沛学,王凤山,张天民.低分子肝素药理作用研究进展[J].食品与药品,2006,8(01A):7-9. 被引量:24
-
5刘向东.应用低分子肝素钙防治骨折术后下肢深静脉血栓形成[J].中国药物与临床,2006,6(12):929-930. 被引量:8
-
6阮长耿.血栓形成机理[J].临床内科,1988,5(3):8-8.
-
7杜秀芳,詹文红,张梅兰,刘伟娜.银杏达莫注射液的临床应用进展[J].临床荟萃,2007,22(18):1367-1368. 被引量:21
-
8Yerdel MA,Gunson B,Mirza D,et al.Portal vein thrombosis in adults undergoing liver transplantation:risk factors,screening,management and outcome.Transplantation,2000,69:1873-1881.
-
9Rattner DW,Ellman L,Warshaw AL.Portal vein thrombosis after elective splenectomy.an underappreciated,potentially lethal syndrome.Arch Surg,1993,128:569-570.
-
10Turnbull B. Prevention of DVT after orthopedic: surgery: the A-V impulse system [ J]. Br J Nursing, 2007, 16 (10) : 612 -615.
引证文献6
-
1罗建春,李爱民,何世安,黄振坚,雷斌,田志强.低分子肝素治疗老年不稳定型心绞痛疗效观察[J].广西医科大学学报,2004,21(6):885-886.
-
2孙卫东.低分子肝素在急性冠状动脉综合征中的合理应用[J].中国社区医师,2007,23(10):15-16.
-
3李燕,俞景奎.早期应用阿司匹林联合低分子肝素钙预防断流术后门静脉系统血栓形成[J].中华普通外科杂志,2010,25(4):299-302. 被引量:10
-
4张福明,孔祥瑞,刘德政,付卫杰,赵志江,杨计策,李广.低分子肝素钙防治老年下肢骨折术后深静脉血栓形成86例[J].中国药业,2010,19(11):57-57. 被引量:25
-
5孙强,彭德付,郑加法.低分子肝素钙联合银杏达莫注射液预防股骨粗隆间骨折术后下肢深静脉血栓形成临床观察[J].中国中西医结合杂志,2011,31(11):1463-1465. 被引量:14
-
6荆山,董燕,胡晓华.低分子量肝素预防股静脉置管后血栓形成的临床疗效[J].浙江创伤外科,2012,17(3):300-302. 被引量:5
二级引证文献53
-
1余学文,董光友.应用药物预防和治疗老年髋关节周围骨折患者下肢深静脉血栓的形成[J].医学信息(医学与计算机应用),2014,0(23):288-289.
-
2钱建敏,舒建国.利伐沙班预防髋关节置换术后深静脉血栓形成60例[J].中国药业,2012,21(5):65-66. 被引量:12
-
3郑崇武,毛建水,叶积飞.利伐沙班预防髋关节周围骨折术后深静脉血栓形成50例[J].中国药业,2012,21(7):80-81. 被引量:13
-
4孙涛,胡瑞斌,周丹亚,魏鹏,滕晓峰,王欣,陈宏.低分子肝素钙联合非洛地平预防穿支皮瓣术后动脉危象疗效研究[J].现代实用医学,2012,24(7):767-769. 被引量:8
-
5邹俊,李学明.门静脉高压症脾切除术后门静脉血栓的形成机制及治疗进展[J].南昌大学学报(医学版),2012,52(7):95-97. 被引量:14
-
6张金梅.低分子肝素在临床特殊应用分析[J].内蒙古中医药,2012,31(18):61-62. 被引量:1
-
7王建明,田秀娥,任强,孙岩,袁海,董典宁,金星.利伐沙班对陈旧性下肢复杂骨折合并弥漫性轴索损伤患者术后下肢深静脉血栓形成的预防[J].临床误诊误治,2012,25(10):40-42. 被引量:2
-
8王莎莎,武家成.门脉高压脾切除加断流术后门脉系统血栓形成相关因素分析[J].现代中西医结合杂志,2012,21(36):4034-4035. 被引量:11
-
9王远平,陈文辉.小剂量肝素钠持续静脉滴注治疗皮神经营养血管逆行皮瓣术后静脉危象34例[J].中国药业,2013,22(1):82-83. 被引量:6
-
10杨诏旭,于恒超,王德盛,杨雁灵,李琳,陶开山,窦科峰.冷沉淀在门奇静脉断流术治疗门静脉高压患者中的应用[J].临床肝胆病杂志,2013,29(1):72-74. 被引量:4
-
1洪燕.血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂与急性冠脉综合征:随机临床试验分析[J].心血管病学进展,2002,23(5).
-
2李洪敏,吴雪琼,刘银萍,白雪娟,贺雄.结核分枝杆菌效应T细胞(FS-Spot)临床试验分析[J].中华临床医师杂志(电子版),2015,9(18):89-91.
-
3刘宏.糖尿病对重度勃起功能障碍及其治疗的影响:他达拉非临床试验分析[J].中华男科学杂志,2007,13(7):671-671.
-
4王天爵,赵树安.Meta-analysis在临床流行病学中的应用[J].中国卫生统计,1993,10(5):58-60. 被引量:16
-
5张新勇,马长生.药物洗脱支架时代多支血管病变血运重建的临床试验评价[J].中国介入心脏病学杂志,2009,17(1):48-50. 被引量:1
-
6陈新,刘俊,隋春兴.急性心肌梗死治疗的临床试验分析[J].医学与哲学(B),2007,28(2):49-51.
-
7徐成斌.糖尿病与心血管并发症[J].当代医学,2001,7(2):45-48.
-
8杨夏慧,阳隽,陈晓军,陈飞鹏.降钙素原检测早期诊断呼吸机相关性肺炎临床价值的Meta分析[J].实用医学杂志,2015,31(13):2186-2189. 被引量:10
-
9喻文,罗红敏.急性呼吸窘迫综合征临床试验二次分析:估计死腔分数[J].中华危重病急救医学,2015,27(10):804-804. 被引量:1
-
10替拉那韦24周Ⅲ期RESIST临床试验结果在《临床传染病杂志》发表[J].国外医药(抗生素分册),2007,28(1):44-45.